| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIP | Common Stock | Sale | $978,021 | -14,850 | -1.9% | $65.86 | 767,770 | 15 May 2024 | Held by Esjay LLC | F1, F2, F3 |
| transaction | ANIP | Common Stock | Sale | $1,050,743 | -16,459 | -2.1% | $63.84 | 751,311 | 16 May 2024 | Held by Esjay LLC | F1, F3, F4 |
| transaction | ANIP | Common Stock | Sale | $362,357 | -5,836 | -0.78% | $62.09 | 745,475 | 17 May 2024 | Held by Esjay LLC | F1, F3, F5 |
| holding | ANIP | Common Stock | 68,652 | 15 May 2024 | Direct | ||||||
| holding | ANIP | Common Stock | 5,000 | 15 May 2024 | Held by SS Pharma LLC | F6 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023. |
| F2 | The shares were sold in multiple trades at prices ranging from $64.66 to $66.54. The price reported above reflects the weighted average sales price. |
| F3 | The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |
| F4 | The shares were sold in multiple trades at prices ranging from $63.28 to $64.90. The price reported above reflects the weighted average sales price. |
| F5 | The shares were sold in multiple trades at prices ranging from $61.43 to $64.00. The price reported above reflects the weighted average sales price. |
| F6 | The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC. |